Entrada Therapeutics Inc
NASDAQ:TRDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Entrada Therapeutics Inc
NASDAQ:TRDA
|
US |
|
Emperor Energy Ltd
ASX:EMP
|
AU |
|
Allogene Therapeutics Inc
NASDAQ:ALLO
|
US |
|
N
|
Newell Brands Inc
XMUN:NWL
|
US |
|
NK Russneft' PAO
MOEX:RNFT
|
RU |
|
M
|
Mitsubishi Heavy Industries Ltd
XMUN:MIH
|
JP |
|
HomeCo Daily Needs REIT
ASX:HDN
|
AU |
|
E
|
Estrima SpA
F:J79
|
IT |
|
Stingray Group Inc
TSX:RAY.A
|
CA |
|
P
|
Principal Financial Group Inc
XMUN:PG4
|
US |
|
S
|
Sri Lotus Developers and Realty Ltd
NSE:LOTUSDEV
|
IN |
|
Lu-Ve SpA
F:V92
|
IT |
|
K
|
Kung Sing Engineering Corp
TWSE:5521
|
TW |
|
B
|
Bioventus Inc
NASDAQ:BVS
|
US |
|
V
|
Verizon Communications Inc
DUS:BAC
|
US |
|
F
|
Frontline Plc
OSE:FRO
|
CY |
Shareholder Yield
Current shareholder yield for TRDA is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
TRDA Price
Entrada Therapeutics Inc
| Average Annual Return | -5.49% |
| Standard Deviation of Annual Returns | 22.78% |
| Max Drawdown | -86% |
| Market Capitalization | 279.2m USD |
| Shares Outstanding | 38 820 000 |
| Percentage of Shares Shorted | 8.45% |
